Efficacy and safety of adapalene 0.3%/benzoyl peroxide 2.5% topical gel in moderate and severe acne vulgaris - 09/05/15
Jonathan Weiss, MD, Gwinnett Clinical Research Center Inc, Snellville, GA, United States; Linda Stein Gold, MD, Henry Ford Medical Center, Department of Dermatology, West Bloomfield, MI, United States; Emil Tanghetti, MD, Center for Dermatology and Laser Surgery, Sacramento, CA, United States; Sophie Bouvresse, MD, Galderma International, La Défense Cedex, France; Min Yao, Galderma Research & Development, Cranbury, NJ, United States; Céline Dujols, Galderma Research & Development, Sophia Antipolis, France; Matthew Leoni, MD, Galderma Research & Development, SNC, Cranbury, NJ, United States
Le texte complet de cet article est disponible en PDF.| Research was funded by Galderma Research & Development, SNC. |
Vol 72 - N° 5S1
P. AB7 - mai 2015 Retour au numéro
Article précédent
- Distribution of TLR-2 and CD1d on epidermis and adnexal structures in adult female acne
- Efficacy and tolerability of oral doxycycline 40 mg modified release with topical metronidazole gel 1% in moderate to severe rosacea
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?